Was machen die Omikron-Impfstoffe besser?
Audio herunterladen:
MP3
Die Paper zu dieser Podcast-Folge:
- Europäische Zulassung Omikron-Impfstoffe "ECDC-EMA statement on booster vaccination with Omicron adapted bivalent COVID-19 vaccines"
- Ewen Callaway, Nature, 2022, "New Omicron-specific vaccines offer similar protection to existing boosters"
- Deborah Cromer et al, medRxiv, 2022, "Predicting the efficacy of variant-modified COVID-19 vaccine boosters"
- Susan Moir et al, medRxiv, 2022, "Recent SARS-CoV-2 infection abrogates antibody and B-cell responses to booster vaccination"
- Michael Edelstein et al, npj Vaccines, 2022, "Association between BNT162b2 vaccination and reported incidence of post-COVID-19 symptoms: cross-sectional study 2020-21, Israel"
- Liu Schan-Lu et al, New England Journal of Medicine, 2022, "Durability of Booster mRNA Vaccine against SARS-CoV-2 BA.2.12.1, BA.4, and BA.5 Subvariants"
Kommentare
Neuer Kommentar